TRVI
Trevi Therapeutics Accelerates Execution in Key Programs
Trevi Therapeutics has entered a pivotal phase of its execution plan, with multiple programs advancing towards key milestones. In a recent conference call, Jennifer Good, President and CEO, provided an update on the company's progress and future plans. One of the key areas of focus is Trevi'